Cargando…

Surgical resection of a renal cell carcinoma involving the inferior vena cava: the role of the cardiothoracic surgeon

BACKGROUND: The techniques for the resection of renal tumors with IVC extension are based on the experience of individual units. We attempt to provide a logical approach of the surgical strategies in a stepwise fashion. METHODS: Over 6-years 9 patients with renal cell carcinoma invading the IVC, und...

Descripción completa

Detalles Bibliográficos
Autores principales: Parissis, Haralabos, Akbar, Mohammad Taukeer, Tolan, Michael, Young, Vincent
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2989311/
https://www.ncbi.nlm.nih.gov/pubmed/21054828
http://dx.doi.org/10.1186/1749-8090-5-103
Descripción
Sumario:BACKGROUND: The techniques for the resection of renal tumors with IVC extension are based on the experience of individual units. We attempt to provide a logical approach of the surgical strategies in a stepwise fashion. METHODS: Over 6-years 9 patients with renal cell carcinoma invading the IVC, underwent surgery. There were 6 males. The extension was at level IV in 4 and III in 5 cases. CPB used in 8 and hypothermia and circulatory arrest in all patients with level IV disease. The results and an algorithm of the plan of action, as per level of extension are presented. RESULTS: Plan of action: For level I-II disease: No Cardiothoracic involvement, For level III: Cardiopulmonary Bypass (CPB) & control of the cavo-atrial junction. For level IV: use of brief periods of Circulatory Arrest & repair of the Cavotomy with a pericardial patch. Postoperative morbidity: prolonged ICU stay, 3 patients (33.3%); tracheostomy, 1 (11.1%); Sepsis, 2 (22.2%); CVA 1, (11.1%). Mortality: 2 patients (22.2%) CONCLUSIONS: Total clearance of the IVC from an adherent tumor is important, therefore extensive level IV disease presents a surgical challenge. We recommend CPB for level III and brief periods of Total Circulatory Arrest (TCA) for level IV disease.